Interventional Cardiology Devices Market Analysis by Top Key Players - Medtronic, Boston Scientific

The Global Interventional Cardiology Devices Market valued at US$ 6.7 billion in 2021 is set to witness a growth rate of ~2 to 3% in the next 5 years.
BRUSSELS - Sept. 30, 2022 - PRLog -- Interventional cardiology is a branch of cardiology that utilizes nonsurgical, catheter-based treatments for structural heart diseases. It makes use of devices such as catheters & sheaths, guidewires, balloons, stents, vascular closure devices, atherectomy devices, intravascular ultrasound (IVUS), and other devices to repair narrowed arteries, damaged or weakened blood vessels, heart valve disorders, and congenital heart diseases.

The rising geriatric population & corresponding rise in the prevalence of coronary artery diseases, rising occurrence of diabetes & concomitant increased risk of coronary heart disease, technical developments in interventional cardiology devices, and favorable reimbursements for interventional cardiology procedures are some of the key factors driving the global interventional cardiology devices market.

APAC to Witness Highest Growth in the Next Five Years
An increasing occurrence of cardiovascular diseases & hypertension, a higher degree of unmet clinical needs, and rising affluence are creating ample opportunities for the interventional cardiology devices market in the APAC region. The development of the interventional cardiology devices market in the APAC is likely to be driven by China and India. Considering the lucrative prospects of the interventional cardiology devices market in the APAC region, prominent companies have expanded their footprint in the region.

For instance,
  • In March 2022, Boston Scientific expanded its footprint in India with its second R&D Center. The new R&D Center addresses the needs of the patients in India, APAC, and around the world. It also provides expertise to all of the company's diverse therapy areas, namely interventional cardiology, peripheral interventions, cardiac rhythm management, endoscopy, neuromodulation, urology, and pelvic health
  • Abbott also intends to expand coverage and resources in training programs related to cardiovascular treatment in China. Abbott owns two training centers in China. The Abbott Medical Advanced Technology Center in Beijing provides doctors with first-class cardiological learning experiences and practice opportunities. The Crossroads-Abbott Academic Center in Shanghai provides interventional treatment training for physicians from different regions in China, making medical treatment and standardized treatment and care more accessible to patients in remote areas
"China is one of the most prominent markets for cardiovascular diseases. The demand from patients to be treated as well as doctors to get trained is humongous. This is why interventional cardiology device manufacturers are investing in China."

Explore Premium Report on Interventional Cardiology Devices Market @

Competitive Landscape Analysis of Interventional Cardiology Devices Market

The interventional cardiology devices market is marked by the presence of players such as Medtronic, Boston Scientific, Abbott, Medinol, Biotronik, SMT, Terumo, Lepu Medical, Microport, among others.

Media Contact
Medi-Tech Insights
+ 32 498 86 80 79
Email:*** Email Verified
Tags:Cardiology Devices Market
Location:Brussels - Brussels - Belgium
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Meditech insights News
Most Viewed
Daily News

Like PRLog?
Click to Share